Search

Your search keyword '"Dhanasekaran, Saravana M."' showing total 430 results

Search Constraints

Start Over You searched for: Author "Dhanasekaran, Saravana M." Remove constraint Author: "Dhanasekaran, Saravana M."
Sorry, I don't understand your search. ×
430 results on '"Dhanasekaran, Saravana M."'

Search Results

2. Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies

4. Comprehensive proteogenomic characterization of rare kidney tumors

6. Pan-cancer proteogenomics characterization of tumor immunity

8. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

9. Proteogenomic insights suggest druggable pathways in endometrial carcinoma

10. Pan-cancer proteogenomics connects oncogenic drivers to functional states

11. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

12. Proteogenomic data and resources for pan-cancer analysis

13. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients—A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT

14. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

16. Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response

17. Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression

20. Proteogenomic characterization of pancreatic ductal adenocarcinoma

21. A proteogenomic portrait of lung squamous cell carcinoma

22. TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma

23. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

24. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

26. KRAS Engages AGO2 to Enhance Cellular Transformation

27. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma

28. The landscape of long noncoding RNAs in the human transcriptome

29. Pan-cancer proteogenomics characterization of tumor immunity

30. Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma

31. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1

32. The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer

33. The Landscape of Circular RNA in Cancer

35. Contemporary Renal Tumor Categorization With Biomarker and Translational Updates: A Practical Review

36. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

37. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays

39. Gene of the month:VSTM2A

40. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients—A Tale of Two Cities

41. Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA

42. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma

43. Deep learning integrates histopathology and proteogenomics at a pan-cancer level

44. Proteogenomic insights suggest druggable pathways in endometrial carcinoma

45. Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA

46. Pan-cancer proteogenomics connects oncogenic drivers to functional states

47. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

48. Proteogenomic data and resources for pan-cancer analysis

50. VSTM2A Overexpression is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney

Catalog

Books, media, physical & digital resources